Stevens & Bolton advised SecurMed UK, the UK Medicines Verification Organisation, on its contract with Arvato Systems GmbH as the IT Blueprint Service Provider for the United Kingdom. The UK is one of the largest and most complex markets for medicines supply within Europe and the appointment of Arvato Systems represents a significant milestone in the UK’s journey to meet its obligations under the Falsified Medicines Directive and associated Delegated Regulation. SecurMed UK and Arvato Systems will be working together to enable the UK medicines supply and healthcare sectors to successfully implement the UK Medicines Verification System by 9 February 2019.
Stevens & Bolton were delighted to support the team at SecurMed UK, an organisation incorporated by the principal supply chain stakeholder associations (Association of British Pharmaceutical Industry, British Association of European Pharmaceutical Distributors, British Generics Manufacturers Association, Company Chemists Association, Healthcare Distribution Association and National Pharmacy Association).
Beverley Flynn, partner, commented “We were delighted to be part of the team advising on such a significant milestone and to play a part in achieving the objective of SecurMed UK, along with its stakeholders from across the medicines supply chain, to ensure a fully FMD compliant service, and end to end Medicines Verification System, is implemented for the UK.”
Jerome Bertin, General Manager, SecurMed UK, said “We are delighted to announce the completion of our contract with Arvato Systems GmbH as the IT Blueprint Service Provider for the UK. Stevens & Bolton played a pivotal role in helping us achieve our objective and we were very pleased to have them on board”.
The Stevens & Bolton team was led by partner Beverley Flynn (commercial & IT), managing associate Charles Maurice (commercial & IT), partner Tim Carter (restructuring & insolvency), partner Keith Syson (corporate) and partner Gustaf Duhs (public & regulatory).